Whalegun
Home

Myriad Genetics MYGN spent $210K on lobbying in Q2 2023 · Budget, Medicare and 1 more issue

Trade details

Type
Lobbying report
Amount
$210,000
Quarter
Q2 2023
Stock
Myriad Genetics MYGN
Client
Myriad Genetics
Reported
23/07/17

Down 46.2% from last quarter

What else happened in Myriad Genetics around then

Filed or reported within 30 days of the trade day · 23/05/31~23/07/30

Myriad Genetics's other lobbying reports

  • Myriad Genetics

    LobbyingMyriad Genetics

    $40K

    Reported 07/20

  • Myriad Genetics

    LobbyingMyriad Genetics

    Under $5,000

    Reported 07/20

  • Myriad Genetics

    LobbyingMyriad Genetics

    $40K

    Reported 07/18

  • Myriad Genetics

    LobbyingMyriad Genetics

    $30K

    Reported 07/17

  • Myriad Genetics

    LobbyingMyriad Genetics

    $10K

    Reported 07/03